Adult Gliosarcoma Terminated Phase 1 Trials for Cilengitide (DB11890)

IndicationStatusPhase
DBCOND0028735 (Adult Gliosarcoma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01122888Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma MultiformeTreatment